Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases

Annals of Surgical Oncology

Volumn 20, Issue 3, 2013, Pages 946-955

  Katz, Steven C ^a   Bamboat, Zubin M ^a   Maker, Ajay V ^a   Shia, Jinru ^a   Pillarisetty, Venu G ^a   Yopp, Adam C ^a   Hedvat, Cyrus V ^a   Gonen, Mithat ^a   Jarnagin, William R ^a   Fong, Yuman ^a   D'Angelica, Michael I ^a   Dematteo, Ronald P ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELL COUNT; CELL INFILTRATION; COLORECTAL CANCER; CYTOTOXIC T LYMPHOCYTE; FEMALE; FOLLOW UP; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROSPECTIVE STUDY; RECURRENCE FREE SURVIVAL; REGULATORY T LYMPHOCYTE; TISSUE MICROARRAY; TUMOR ASSOCIATED LEUKOCYTE;

ADULT; AGED; AGED, 80 AND OVER; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; LIVER NEOPLASMS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 84875225709     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2668-9     Document Type: Article

References (38)

1. CG Clemente MC Mihm Jr R Bufalino S Zurrida P Collini N Cascinelli 1996 Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma Cancer. 77 1303 1310 8608507 10.1002/(SICI)1097- 0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5 1:STN:280: DyaK287pslChtA%3D%3D
2. J Fu D Xu Z Liu M Shi P Zhao B Fu, et al. 2007 Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients Gastroenterology. 132 2328 2339 17570208 10.1053/j.gastro. 2007.03.102
3. J Galon A Costes F Sanchez-Cabo A Kirilovsky B Mlecnik C Lagorce-Pagès, et al. 2006 Type, density, and location of immune cells within human colorectal tumors predict clinical outcome Science. 313 1960 1964 17008531 10.1126/science.1129139 1:CAS:528:DC%2BD28XhtVSnsrnK
4. F Pages A Berger M Camus F Sanchez-Cabo A Costes R Molidor, et al. 2005 Effector memory T cells, early metastasis, and survival in colorectal cancer New Engl J Med. 353 2654 2666 16371631 10.1056/NEJMoa051424 1:CAS:528: DC%2BD2MXhtlarsrrE
5. L Zhang JR Conejo-Garcia D Katsaros PA Gimotty M Massobrio G Regnani, et al. 2003 Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer New Engl J Med. 348 203 213 12529460 10.1056/NEJMoa020177 1:CAS:528:DC%2BD3sXksVehug%3D%3D
6. B Mlecnik M Tosolini A Kirilovsky A Berger G Bindea T Meatchi, et al. 2011 Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction J Clin Oncol. 29 610 618 21245428 10.1200/JCO.2010.30.5425
7. Y Fong J Fortner RL Sun MF Brennan LH Blumgart 1999 Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases Ann Surg. 230 309 318 10493478 10.1097/00000658-199909000-00004 1:STN:280:DyaK1MvitFahsw%3D%3D discussion 18-21.
8. JS Tomlinson WR Jarnagin RP DeMatteo Y Fong P Kornprat M Gonen, et al. 2007 Actual 10-year survival after resection of colorectal liver metastases defines cure J Clin Oncol. 25 4575 4580 17925551 10.1200/JCO.2007.11.0833
9. SC Katz VG Pillarisetty JI Bleier TP Kingham UI Chaudhry AB Shah, et al. 2005 Conventional liver CD4 T cells are functionally distinct and suppressed by environmental factors Hepatology. 42 293 300 16025518 10.1002/hep.20795
10. SC Katz VG Pillarisetty JI Bleier AB Shah RP DeMatteo 2004 Liver sinusoidal endothelial cells are insufficient to activate T cells J Immunol. 173 230 235 15210779 1:CAS:528:DC%2BD2cXltVajtb0%3D
11. TP Kingham UI Chaudhry G Plitas SC Katz J Raab RP DeMatteo 2007 Murine liver plasmacytoid dendritic cells become potent immunostimulatory cells after Flt-3 ligand expansion Hepatology. 45 445 454 17256750 10.1002/hep.21457 1:CAS:528:DC%2BD2sXisVKnsrY%3D
12. VG Pillarisetty AB Shah G Miller JI Bleier RP DeMatteo 2004 Liver dendritic cells are less immunogenic than spleen dendritic cells because of differences in subtype composition J Immunol. 172 1009 1017 14707074 1:CAS:528:DC%2BD2cXnsl2j
13. ZM Bamboat JA Stableford G Plitas BM Burt HM Nguyen AP Welles, et al. 2009 Human liver dendritic cells promote T cell hyporesponsiveness J Immunol. 182 1901 1911 19201843 10.4049/jimmunol.0803404 1:CAS:528:DC%2BD1MXhsFKktb0%3D
14. A Goubier B Dubois H Gheit G Joubert F Villard-Truc C Asselin-Paturel, et al. 2008 Plasmacytoid dendritic cells mediate oral tolerance Immunity. 29 464 475 18789731 10.1016/j.immuni.2008.06.017 1:CAS:528:DC%2BD1cXhtF2jtLjF
15. SC Katz V Pillarisetty ZM Bamboat J Shia C Hedvat M Gonen, et al. 2009 T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastases Ann Surg Oncol. 16 2524 2530 19568816 10.1245/s10434-009-0585-3
16. SC Katz C Donkor K Glasgow VG Pillarisetty M Gönen NJ Espat, et al. 2010 T cell infiltrate and outcome following resection of intermediate-grade primary neuroendocrine tumours and liver metastases HPB (Oxford). 12 674 683 10.1111/j.1477-2574.2010.00231.x
17. T Cohen D Prus J Shia B Abu-Wasel MG Pinto HR Freund, et al. 2008 Expression of P53, P27 and KI-67 in colorectal cancer patients of various ethnic origins: clinical and tissue microarray based analysis J Surg Oncol. 97 416 422 18286523 10.1002/jso.20989
18. R Miller D Siegmund 1982 Maximally selected chi square statistics Biometrics. 38 1011 1016 10.2307/2529881
19. MG House H Ito M Gonen PJ Allen RP DeMatteo MF Brennan, et al. 2010 Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution J Am Coll Surg. 210 744-52 752 755
20. E Sato SH Olson J Ahn B Bundy H Nishikawa F Qian, et al. 2005 Intraepithelial CD8 + tumor-infiltrating lymphocytes and a high CD8 +/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer Proc Natl Acad Sci U S A. 102 18538 18543 16344461 10.1073/pnas.0509182102 1:CAS:528:DC%2BD28Xpt1Om
21. N Halama S Michel M Kloor I Zoernig A Benner A Spille, et al. 2011 Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapy Cancer Res. 71 5670 5677 21846824 10.1158/0008-5472.CAN-11-0268 1:CAS:528:DC%2BC3MXhtFSmtb3F
22. J Galon WH Fridman F Pages 2007 The adaptive immunologic microenvironment in colorectal cancer: a novel perspective Cancer Res. 67 1883 1886 17332313 10.1158/0008-5472.CAN-06-4806 1:CAS:528:DC%2BD2sXit12qtbo%3D
23. Wagner P, Koch M, Nummer D, Palm S, Galindo L, Autenrieth D, et al. Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer. Ann Surg Oncol. 2008;15:2310-7. Erratum in: Ann Surg Oncol. 2009;16:1084. Rahbari, Nuh [added].
24. PA Antony CA Piccirillo A Akpinarli SE Finkelstein PJ Speiss DR Surman, et al. 2005 CD8 + T cell immunity against a tumor/self-antigen is augmented by CD4 + T helper cells and hindered by naturally occurring T regulatory cells J Immunol. 174 2591 2601 15728465 1:CAS:528:DC%2BD2MXhsFeru7Y%3D
25. WM Liu DW Fowler P Smith AG Dalgleish 2010 Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses Br J Cancer. 102 115 123 19997099 10.1038/sj.bjc.6605465 1:CAS:528:DC%2BC3cXhtFOkug%3D%3D
26. Y Ma L Aymeric C Locher SR Mattarollo NF Delahaye P Pereira, et al. 2011 Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy J Exp Med. 208 491 503 21383056 10.1084/jem.20100269 1:CAS:528:DC%2BC3MXjslCmtro%3D
27. B Melichar M Touskova P Vesely 2002 Effect of irinotecan on the phenotype of peripheral blood leukocyte populations in patients with metastatic colorectal cancer Hepatogastroenterology. 49 967 970 12143255 1:CAS:528:DC%2BD38XlvFOrur0%3D
28. S Hori T Nomura S Sakaguchi 2003 Control of regulatory T cell development by the transcription factor Foxp3 Science. 299 1057 1061 12522256 10.1126/science.1079490 1:CAS:528:DC%2BD3sXhtFarsbw%3D
29. N Hiraoka K Onozato T Kosuge S Hirohashi 2006 Prevalence of FOXP3 + regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions Clin Cancer Res. 12 5423 5434 17000676 10.1158/1078-0432.CCR-06-0369 1:CAS:528:DC%2BD28XpvFShsLc%3D
30. N Kobayashi N Hiraoka W Yamagami H Ojima Y Kanai T Kosuge, et al. 2007 FOXP3 + regulatory T cells affect the development and progression of hepatocarcinogenesis Clin Cancer Res. 13 902 911 17289884 10.1158/1078-0432.CCR- 06-2363 1:CAS:528:DC%2BD2sXhsVyrsL8%3D
31. D Hirschhorn-Cymerman GA Rizzuto T Merghoub AD Cohen F Avogadri AM Lesokhin, et al. 2009 OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis J Exp Med. 206 1103 1116 19414558 10.1084/jem.20082205 1:CAS:528:DC%2BD1MXlvVGmurY%3D
32. SA Quezada KS Peggs MA Curran JP Allison 2006 CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells J Clin Invest. 116 1935 1945 16778987 10.1172/JCI27745 1:CAS:528:DC%2BD28XmvV2lurw%3D
33. K Naylor G Li AN Vallejo WW Lee K Koetz E Bryl, et al. 2005 The influence of age on T cell generation and TCR diversity J Immunol. 174 7446 7452 15905594 1:CAS:528:DC%2BD2MXkt1OlsLw%3D
34. SE Allan SQ Crome NK Crellin L Passerini TS Steiner R Bacchetta, et al. 2007 Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production Int Immunol. 19 345 354 17329235 10.1093/intimm/dxm014 1:CAS:528:DC%2BD2sXjsleku7Y%3D
35. ME Morgan JH van Bilsen AM Bakker B Heemskerk MW Schilham FC Hartgers, et al. 2005 Expression of FOXP3 mRNA is not confined to CD4 + CD25 + T regulatory cells in humans Hum Immunol. 66 13 20 15620457 10.1016/j.humimm.2004.05.016 1:CAS:528:DC%2BD2cXhtFGhsLrJ
36. JR Brahmer SS Tykodi LQ Chow WJ Hwu SL Topalian P Hwu, et al. 2012 Safety and activity of anti-PD-L1 antibody in patients with advanced cancer New Engl J Med. 366 2455 2465 22658128 10.1056/NEJMoa1200694 1:CAS:528:DC%2BC38XhtV2rsbnJ
37. SL Topalian FS Hodi JR Brahmer SN Gettinger DC Smith DF McDermott, et al. 2012 Safety, activity, and immune correlates of anti-PD-1 antibody in cancer New Engl J Med. 366 2443 2454 22658127 10.1056/NEJMoa1200690 1:CAS:528:DC%2BC38XhtV2rs7fN
38. FS Hodi SJ O'Day DF McDermott RW Weber JA Sosman JB Haanen, et al. 2010 Improved survival with ipilimumab in patients with metastatic melanoma New Engl J Med. 363 711 723 20525992 10.1056/NEJMoa1003466 1:CAS:528:DC%2BC3cXhtVCrtrbN